Table II.
Parameter | Total NPb | MYC overexpression | ||
---|---|---|---|---|
Yes NP (%) | No NP (%) | p value | ||
Total | 30 | 11 | 19 | |
NSCLC subtype | ||||
Adenocarcinoma | 9 | 0 (0.0) | 9 (100.0) | 0.01c |
Squamous cell carcinoma | 21 | 11 (52.4) | 10 (47.6) | |
Histological gradea | ||||
g1/2 | 26 | 11 (42.3) | 15 (57.7) | 0.36 |
g3 | 4 | 0 (0.0) | 4 (100.0) | |
Stage | ||||
I/II | 16 | 6 (37.5) | 10 (62.5) | 1 |
III | 14 | 5 (35.7) | 9 (64.3) | |
Lymph node invasion | ||||
Positive | 25 | 9 (36.0) | 16 (64.0) | 1 |
Negative | 5 | 2 (40.0) | 3 (60.0) |
NP number of patients per group;
bold indicates statistically significant value, p<0.05.
g1/2, well to moderately differentiated; g3, poorly differentiated;